Plasma Levels of Vascular Endothelial Growth Factor and Selected Hemostatic Parameters in Association With Treatment Response in Multiple Myeloma
Multiple myeloma (MM) is a neoplastic plasma cell disorder characterized by the clonal proliferation of plasma cells in the bone marrow and presence of monoclonal protein in the blood or urine. Diverse hemostatic abnormalities have been reported in patients with myeloma which predispose the patient...
Main Authors: | Juraj Sokol MD, PhD, Matej Hrncar MD, Frantisek Nehaj MD, Jan Stasko MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-02-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/1076029618823280 |
Similar Items
-
Impact of Dabigatran Treatment on Rotation Thromboelastometry
by: Juraj Sokol MD, PhD, et al.
Published: (2021-01-01) -
Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor
by: Takeshi Matsumoto MD, PhD, et al.
Published: (2019-01-01) -
The Evaluation of Hemostatic Abnormalities Using a CWA-Small Amount Tissue Factor Induced FIX Activation Assay in Major Orthopedic Surgery Patients
by: Masahiro Hasegawa MD, PhD, et al.
Published: (2021-05-01) -
Safety, Immunogenicity, and Hemostatic Efficacy of Nonacog Gamma in Patients With Severe or Moderately Severe Hemophilia B: A Continuation Study
by: Jerzy Windyga MD, PhD, et al.
Published: (2020-08-01) -
VASCULAR-1 and VASCULAR-2 as a New Potential Angiogenesis and Endothelial Dysfunction Markers in Peripheral Arterial Disease
by: Radosław Wieczór MD, PhD, et al.
Published: (2019-09-01)